Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by IQVIA

< Previous 1 2 3 Next >
IQVIA Receives WCG Pinnacle Award for Excellence in Site Relationships
From IQVIA
Via Business Wire
Tickers IQV
IQVIA Announces Launch of Clinical Trial Financial Suite, a Next-Generation Platform for Integrated Financial Management
From IQVIA
Via Business Wire
Tickers IQV
IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes
From IQVIA
Via Business Wire
Tickers IQV VEEV
IQVIA to Announce Second-Quarter 2025 Results on July 22, 2025
From IQVIA
Via Business Wire
Tickers IQV
IQVIA Health Research Space Wins 2025 MedTech Breakthrough Award for ‘Best Mobile App for Patient Engagement’
From IQVIA
Via Business Wire
Tickers IQV
IQVIA Launches New AI Agents for Life Sciences and Healthcare
From IQVIA
Via Business Wire
Tickers IQV
IQVIA and SCRI Collaborate to Accelerate Global Oncology Trials
From IQVIA
Via Business Wire
Tickers IQV
IQVIA celebrates Marie E. Lamont and Dr. Joanne Hackett, winners of Healthcare Businesswomen's Association Awards
From IQVIA
Via Business Wire
Tickers IQV
IQVIA named a front-runner in generative AI innovation by global industry research and analysis firm
From IQVIA
Via Business Wire
Tickers IQV
IQVIA to Announce First-Quarter 2025 Results on May 6, 2025
From IQVIA
Via Business Wire
Tickers IQV
IQVIA recognized as a leader in IDC MarketScape’s 2024 assessment for decentralized clinical trial technologies and consulting services
From IQVIA
Via Business Wire
Tickers IQV
IQVIA Laboratories launches Site Lab Navigator with breakthrough e-Requisition innovation to transform clinical trials
From IQVIA
Via Business Wire
Tickers IQV
IQVIA AI Assistant wins 2024 PM360 Innovation Award for Artificial Intelligence
From IQVIA
Via Business Wire
Tickers IQV
IQVIA CFO Ron Bruehlman to Speak at the TD Cowen Annual Health Care Conference on March 4, 2025
From IQVIA
Via Business Wire
Tickers IQV
IQVIA Releases 2024 Sustainability Report
From IQVIA
Via Business Wire
Tickers IQV
IQVIA named to the Fortune® World’s Most Admired Companies™ list, ranked No. 1 in its sector for fourth consecutive year
From IQVIA
Via Business Wire
Tickers IQV
IQVIA to Announce Fourth-Quarter and Full-Year 2024 Results on February 6, 2025
From IQVIA
Via Business Wire
Tickers IQV
IQVIA and NVIDIA Collaborate to Transform Healthcare and Life Sciences Through Advanced Agentic AI Solutions
From IQVIA
Via Business Wire
Tickers IQV
Digital Health Tools are Expanding in Scope and Function to Aid Patient Diagnosis, Treatment and Monitoring, Says New Report from The IQVIA Institute
From IQVIA
Via Business Wire
Tickers IQV
IQVIA Announces IQVIA AI Assistant, Powered by IQVIA Healthcare-grade AI™
From IQVIA
Via Business Wire
Tickers IQV
IQVIA AI Solution Receives 2024 Frost & Sullivan Global Customer Value Leadership Award
From IQVIA
Via Business Wire
Tickers IQV
IQVIA Named a Leader in Medical Affairs and Regulatory Operations by Everest Group
From IQVIA
Via Business Wire
Tickers IQV
IQVIA’s SmartSolve® eQMS Wins 2024 MedTech Breakthrough Award “Best Use of Artificial Intelligence in Healthcare”
From IQVIA
Via Business Wire
Tickers IQV
IQVIA Launches “One Home” Clinical Trial Technology Platform – Solves Challenges and Reduces Overload at Sites
From IQVIA
Via Business Wire
Tickers IQV
IQVIA Institute: Innovative Therapies and Strong Pipeline to Combat Rise in Cancer Diagnoses
From IQVIA
Via Business Wire
Tickers IQV
U.S. Medicines Spending Grew in 2023 as Greater Access Offset COVID-19-related Decline, Says IQVIA Institute
From IQVIA
Via Business Wire
Tickers IQV
IQVIA Celebrates Wendy Stewart and Susan Barnes, Winners of Healthcare Businesswoman's Association Luminary and Rising Star Awards
From IQVIA
Via Business Wire
Tickers IQV
IQVIA and Salesforce Expand Global Partnership to Accelerate the Development of Life Sciences Cloud
From IQVIA
Via Business Wire
Tickers IQV
IQVIA Publishes its 2023 Environmental, Social and Governance Report
From IQVIA
Via Business Wire
Tickers IQV
Global Biopharma R&D Boasts Increased Funding, Productivity and Product Launches in 2023, says IQVIA Institute Report
From IQVIA
Via Business Wire
Tickers IQV
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.